Esophagogastric Junction Morphology is Associated with a Positive Impedance-pH Monitoring in Patients with GERD
Overview
Neurology
Authors
Affiliations
Background: High-resolution manometry (HRM) provides information on esophagogastric junction (EGJ) morphology, distinguishing three different subtypes. Data on the correlation between EGJ subtypes and impedance-pH detected reflux patterns are lacking. We aimed to correlate the EGJ subtypes with impedance-pH findings in patients with reflux symptoms.
Methods: Consecutive patients with suspected gastroesophageal reflux disease (GERD) were enrolled. All patients underwent HRM and impedance-pH testing off-therapy. EGJ was classified as: Type I, no separation between the lower esophageal sphincter (LES) and crural diaphragm (CD); Type II, minimal separation (>1 and <2 cm); Type III, ≥ 2 cm separation. We measured esophageal acid exposure time (AET), number of total reflux episodes and symptom association analysis.
Key Results: We enrolled 130 consecutive patients and identified 46.2% Type I EGJ, 38.5% Type II, and 15.4% Type III patients. Type III subjects had a higher number of reflux episodes (61 vs 45, p < 0.03, vs 25, p < 0.001), a greater mean AET (12.4 vs 4.2, p < 0.02, vs 1.5, p < 0.001) and a greater positive symptom association (75% vs 72%, p = 0.732 vs 43.3%, p < 0.02) compared with Type II and I patients, respectively. Furthermore, Type II subjects showed statistically significant (overall p < 0.01) increased reflux when compared with Type I patients. Type III and II EGJ morphologies had a more frequent probability to show a positive multichannel intraluminal impedance pH monitoring than Type I (95% vs 84% vs 50%, p < 0.001).
Conclusions & Inferences: Increasing separation between LES and CD can cause a gradual and significant increase in reflux. EGJ morphology may be useful to estimate an abnormal impedance-pH testing in GERD patients.
Established and Novel Methods to Assess GERD: An Update.
Schweckendiek D, Pohl D Visc Med. 2024; 40(6):331-338.
PMID: 39664095 PMC: 11631016. DOI: 10.1159/000540186.
Utilizing Esophageal Motility Tests in Diagnosing and Evaluating Gastroesophageal Reflux Disease.
Yang W, Huang Y, He L, Chen D, Wu S, Tian Y Diagnostics (Basel). 2024; 14(14).
PMID: 39061603 PMC: 11276196. DOI: 10.3390/diagnostics14141467.
Esophageal motor abnormalities in gastroesophageal reflux disorders.
Lei W, Yi C, Liu T, Hung J, Wong M, Chen C Tzu Chi Med J. 2024; 36(2):120-126.
PMID: 38645779 PMC: 11025585. DOI: 10.4103/tcmj.tcmj_209_23.
Zerbib F United European Gastroenterol J. 2024; 12(5):537-538.
PMID: 38638028 PMC: 11176898. DOI: 10.1002/ueg2.12573.
Siboni S, Sozzi M, Kristo I, Boveri S, Rogers B, De Bortoli N United European Gastroenterol J. 2024; 12(5):552-561.
PMID: 38536701 PMC: 11176912. DOI: 10.1002/ueg2.12565.